(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer

NCT02132403 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Drug Recall

Conditions

Pancreatic Cancer

Interventions

DRUG: BTH1704
DRUG: IMPRIME PGG
DRUG: Gemcitabine

Sponsor

University of Illinois at Chicago

Collaborators

[object Object]